JamesLewisPoolMD

Diabetes, Lipid Metabolism

Professor, Medicine, Baylor College of Medicine

Dr. Pool is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
6620 Main St
Houston, TX 77030
Phone+1 713-798-2500

Fax+1 713-798-2505

Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1976
Duke University HospitalResidency, Internal Medicine, 1972 - 1975
University of Oklahoma College of MedicineClass of 1972

PubMed

167 citations
Aliskiren, an Orally Effective Renin Inhibitor, Provides Antihypertensive Efficacy Alone and in Combination With Valsartan
James L. Pool, Roland E. Schmieder, Michel Azizi, Jean-Claude Aldigier, Andrzej Januszewicz
American Journal of Hypertension. 2007-01-01
87 citations
Expanded clinical evaluation of lovastatin (EXCEL) study results: Two-year efficacy and safety follow-up
Reagan H. Bradford, Charles L. Shear, Athanassios N. Chremos, Carlos A. Dujovne, Frank A. Franklin
The American Journal of Cardiology. 1994-10-01
35 citations
Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II—receptor blocker
James L. Pool, Suzanne Oparil, Thomas Hedner, Robert Glazer, Pascale Oddou-Stock
Clinical Therapeutics. 1998-11-01

Comparison Of Hytrin-Cr With Placebo In Patients With Moderate HypertensionNational Center For Research Resources1992
Pharmacokinetics Of Terazosin And Verapamil In Treatment Of HypertensionNational Center For Research Resources1991
Terazosin And Verapamil In Essential HypertensionNational Center For Research Resources1987